1. Home
  2. NBIX vs CUBE Comparison

NBIX vs CUBE Comparison

Compare NBIX & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • CUBE
  • Stock Information
  • Founded
  • NBIX 1992
  • CUBE 2004
  • Country
  • NBIX United States
  • CUBE United States
  • Employees
  • NBIX N/A
  • CUBE N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • CUBE Real Estate Investment Trusts
  • Sector
  • NBIX Health Care
  • CUBE Real Estate
  • Exchange
  • NBIX Nasdaq
  • CUBE Nasdaq
  • Market Cap
  • NBIX 13.1B
  • CUBE 10.5B
  • IPO Year
  • NBIX 1996
  • CUBE 2004
  • Fundamental
  • Price
  • NBIX $135.45
  • CUBE $43.29
  • Analyst Decision
  • NBIX Buy
  • CUBE Hold
  • Analyst Count
  • NBIX 23
  • CUBE 11
  • Target Price
  • NBIX $165.00
  • CUBE $51.36
  • AVG Volume (30 Days)
  • NBIX 910.2K
  • CUBE 1.2M
  • Earning Date
  • NBIX 02-05-2025
  • CUBE 10-31-2024
  • Dividend Yield
  • NBIX N/A
  • CUBE 4.64%
  • EPS Growth
  • NBIX 97.40
  • CUBE 5.93
  • EPS
  • NBIX 3.73
  • CUBE 1.78
  • Revenue
  • NBIX $2,242,800,000.00
  • CUBE $1,066,921,000.00
  • Revenue This Year
  • NBIX $27.07
  • CUBE N/A
  • Revenue Next Year
  • NBIX $16.60
  • CUBE $3.04
  • P/E Ratio
  • NBIX $36.12
  • CUBE $24.32
  • Revenue Growth
  • NBIX 25.72
  • CUBE 1.56
  • 52 Week Low
  • NBIX $110.95
  • CUBE $39.80
  • 52 Week High
  • NBIX $157.98
  • CUBE $55.14
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 68.12
  • CUBE 20.91
  • Support Level
  • NBIX $125.61
  • CUBE $46.09
  • Resistance Level
  • NBIX $130.48
  • CUBE $47.76
  • Average True Range (ATR)
  • NBIX 2.92
  • CUBE 0.86
  • MACD
  • NBIX 0.72
  • CUBE -0.40
  • Stochastic Oscillator
  • NBIX 69.33
  • CUBE 0.07

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

Share on Social Networks: